| pubmed-article:21492878 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0038454 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0449820 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0034975 | lld:lifeskim |
| pubmed-article:21492878 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:21492878 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:21492878 | pubmed:dateCreated | 2011-6-13 | lld:pubmed |
| pubmed-article:21492878 | pubmed:abstractText | The aim of this study was to examine whether CHADS(2) score is associated with clinical outcomes following recombinant tissue type plasminogen activator (rt-PA) therapy in stroke patients with atrial fibrillation (AF). | lld:pubmed |
| pubmed-article:21492878 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21492878 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21492878 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21492878 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21492878 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21492878 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21492878 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:21492878 | pubmed:issn | 1878-5883 | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:ToyodaKazunor... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:KimuraKazumiK | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:KarioKazuomiK | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:ShiokawaYoshi... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:KogaMasatoshi... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:MinematsuKazu... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:OkadaYasushiY | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:YamagamiHiros... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:HasegawaYasuh... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:NaganumaMasak... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:FuruiEisukeE | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:NakagawaraJyo... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:OkudaSatoshiS | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:ShibazakiKens... | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:NezuTomohisaT | lld:pubmed |
| pubmed-article:21492878 | pubmed:author | pubmed-author:MaedaKoichiro... | lld:pubmed |
| pubmed-article:21492878 | pubmed:copyrightInfo | Copyright © 2011 Elsevier B.V. All rights reserved. | lld:pubmed |
| pubmed-article:21492878 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21492878 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:21492878 | pubmed:volume | 306 | lld:pubmed |
| pubmed-article:21492878 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21492878 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21492878 | pubmed:pagination | 49-53 | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:meshHeading | pubmed-meshheading:21492878... | lld:pubmed |
| pubmed-article:21492878 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21492878 | pubmed:articleTitle | CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry. | lld:pubmed |
| pubmed-article:21492878 | pubmed:affiliation | Division of Stroke Care Unit, National Cerebral and Cardiovascular Center, Suita, Japan. | lld:pubmed |
| pubmed-article:21492878 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21492878 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
